1. One-Year Follow-Up of Healthy Older Adults with Electroencephalographic Risk for Neurocognitive Disorder After Neurofeedback Training
- Author
-
Graciela C. Alatorre-Cruz, Thalía Fernández, Susana A. Castro-Chavira, Mauricio González-López, Sergio M. Sánchez-Moguel, and Juan Silva-Pereyra
- Subjects
Male ,General Neuroscience ,Neurocognitive Disorders ,Electroencephalography ,General Medicine ,Neurofeedback ,Healthy Volunteers ,Psychiatry and Mental health ,Clinical Psychology ,Cognitive Aging ,Humans ,Female ,Theta Rhythm ,Geriatrics and Gerontology ,Aged ,Follow-Up Studies - Abstract
Background: In healthy older adults, excess theta activity is an electroencephalographic (EEG) predictor of cognitive impairment. In a previous study, neurofeedback (NFB) treatment reinforcing reductions theta activity resulted in EEG reorganization and cognitive improvement. Objective: To explore the clinical applicability of this NFB treatment, the present study performed a 1-year follow-up to determine its lasting effects. Methods: Twenty seniors with excessive theta activity in their EEG were randomly assigned to the experimental or control group. The experimental group received an auditory reward when the theta absolute power (AP) was reduced. The control group received the reward randomly. Results: Both groups showed a significant decrease in theta activity at the training electrode. However, the EEG results showed that only the experimental group underwent global changes after treatment. These changes consisted of delta and theta decreases and beta increases. Although no changes were found in any group during the period between the posttreatment evaluation and follow-up, more pronounced theta decreases and beta increases were observed in the experimental group when the follow-up and pretreatment measures were compared. Executive functions showed a tendency to improve two months after treatment which became significant one year later. Conclusion: These results suggest that the EEG and behavioral benefits of this NFB treatment persist for at least one year, which adds up to the available evidence contributing to identifying factors that increase its efficacy level. The relevance of this study lies in its prophylactic features of addressing a clinically healthy population with EEG risk of cognitive decline.
- Published
- 2022
- Full Text
- View/download PDF